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Background: Regardless of the kind of biomaterial used for the graft, it is clear that, over time, the graft undergoes 
dimensional changes that could influence the final bone volume obtained, which could alter the stability of the 
installed implants. The aim of the present study was to compared and correlated the graft behavior with the amount 
(in grams) of xenogeneic and alloplastic biomaterials used in grafts for maxillary sinus lift. 
Material and Methods: This retrospective cohort study used 148 CBCT images of 74 grafts from 68 maxillary sinu-
ses lift patients in a university, post-graduate clinic. The weights of biomaterials, categorized in intervals according 
to amount used, were correlated with the graft volumes at V1 (10 days) and V2 (180 days). Kruskal-Wallis test was 
used to evaluate the possible bias effect of weight on graft maintenance. 
Results: Mean weights of biomaterials used were: Bio-Oss Small® (1.58g); Bio-Oss Large® (1.35g); Endobon® 
(0.72g); BoneCeramic®+Emdogaim® (0.96g); Cerasorb® (1.13g) and Osteogen® (2.70g). No significant diffe-
rences (p>0.05). Were found for the influence of these mean amounts in graft maintenance: Bio-Oss Small® (18); 
Bio-Oss Large® (10); Endobon® (17); BoneCeramic®+Emdogaim® (10); Cerasorb® (11); and Osteogen® (08) 
at V1 and V2. However, when biomaterials were categorized by intervals, all Cerasorb® interval groups showed 
statistically significant differences (p<0.001) in graft volume at V2. 
Conclusions: The amounts of the biomaterials used could influence the final volume; depending on the biomaterial 
characteristics. Implant installation was possible with all studied grafts, although graft volume shrinkage should be 
considered when selecting biomaterial for sinus lift.
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Introduction
Biomaterials with osteoconductive capacity were eva-
luated in maxillary sinus lift, obtaining results equiva-
lent to those of autogenous grafts (1). The xenogeneic 
and alloplastic hydroxyapatites present as viable alter-
natives for maxillary sinus lift (2-5).
Regardless of the kind of biomaterial used for the graft, 
it is clear that, over time, the graft undergoes dimensio-
nal changes that could influence the final bone volume 
obtained, which could alter the stability of the installed 
implants (2-6).
The use of computed tomography (CT) to analyze the 
bone volume achieved after maxillary sinus is reported 
in the literature as an accurate method, which produces 
reliable images with little distortion (6-14).
In this context, there are studies (4,6,11-22) using diffe-
rent biomaterials evaluating the graft shrinkage and the 
bone formation. However, scientific information concer-
ning the influence of the amount of biomaterial used to 
obtain the initial and final volumes of the graft during 
maxillary sinus lift, has still not been identified in the 
literature.
There being several alternatives regarding the choice 
of graft biomaterials for maxillary sinus lift, the pre-
sent study aims to evaluate the possible bias effect of 
the amount of biomaterials on graft volume maintenan-
ce, comparing and correlating graft volumes with the 
amount (in grams) of different xenogeneic and alloplas-
tic biomaterials, used for maxillary sinus lift grafts. 
Material and Methods
The present study was approved by the PUCMINAS - 
Catholic University, Post-graduate Research Implant 
Clinic, Belo Horizonte, Brazil, - ethics committee, num-
ber CAAE 02663212.9.0000.5137. 
This retrospective cohort observational study analyzed 
80 maxillary sinuses lift patients records from PUCMI-
NAS between 2014 and 2018. After inclusion and exclu-
sion patients’ criteria, the present study used 68 patients 
records, whose was planning maxillary implant over-
denture prosthesis. 
-Patient selection
The inclusion criteria patients’ data selection was deter-
mined by the complete maxillary tomographic exams 
obtained between the 5th and 7th day and 180-day 
post-surgery. It’s important to stress that the tomographic 
exam in the first period of the study at 7 to 10 days was 
done as part of the University Surgical Clinical protocol 
(11-13), to check correct graft accommodation, any in-
filtration of the biomaterial in the sinus cavity, membra-
ne height or other intercurrence that could interfere with 
the sinus graft healing or could induced in maxillary 
sinusitis (23-25) and 180-day post-surgery was done 
to plan the implant installation. All those patients were 
maxillary complete edentulous, with a residual alveolar 
ridge height <4mm, and a  total mean volume found for 
the maxillary sinuses of 15.65cm3 (13).
As exclusion criteria patients had autoimmune diseases, 
diabetes mellitus, alcoholism, smoker, stress (required 
sedation), active periodontal diseases, maxillary sinus 
diseases or surgeries, or that had some intercurrences 
like membrane perforations, biomaterials sinus incur-
sions, sinus infections, during or after the sinus lift graft 
procedure, were removed from the data study.
-Surgical procedure
All surgeries were performed by clinical specialists 
according PUCMINAS Implant Dentistry Department 
protocol (11,12). After administering local anesthesia 
with lidocaine 1:100.000 (Alphacaína® - DFL) a ho-
rizontal incision was made on the crest of the alveolar 
ridge and two vertical incisions beyond the gingival mu-
cus line. A full thickness flap exposed the lateral wall of 
the maxillary sinus. An oval-shaped bone window with 
a final regular size of 08mm to 10mm height and 10mm 
to 18mm width, was obtained by osteotomy of the maxi-
llary sinus lateral wall.  A number 8 spherical diamond 
drill was used under constant sterile saline irrigation for 
this procedure. The remaining bone in the center of the 
window, attached to the maxillary sinus membrane, was 
folded into the sinus cavity during the detachment of the 
membrane. 
The sinus cavity obtained was filled with a selected bio-
material according to the previously choice of surgeons 
and patients. The biomaterials used were: anorganic bo-
vine bone (BioOss®-Small and Bio-Oss® Large, Geist-
lich Biomaterials, Wolhusen, Switzerland); anorganic 
bovine (Endobon® RegenerOsst, BIOMET3i, Palm 
Beach Gardens, FL, USA); biphasic phosphate Bone 
Ceramic® + protein enamel matrix Emdogain® (Strau-
mann, Basel, Switzerland), tricalcium phosphate (Cera-
sorb® M Dental Curasan, Frankfurt/Main, Germany); 
and hydroxyapatite (Osteogen®, Intra-lock® System, 
USA).
The amount of biomaterial used during the sinus lift sur-
gery is determined according to the number of implants 
and their spatial distribution based on the prosthetic 
planning for overdentures using a total of four implants. 
All the biomaterials were carefully applied dry in the 
surgical sinus areas, according to the necessary amount. 
Regarding the intended degree of the height sinus fi-
lling, all the grafts must permit the installation of 9mm 
to 11mm long implants, after a healing period of 180 
days. A sample of each biomaterial was weighed using 
a precision balance to check that it complies with the 
manufacturer’s information, to a precision of 0.01g. The 
bone window was covered with a collagen membrane 
(Surgidry-film, Technodry, Brazil) and the flap was re-
positioned without tension and sutured appropriately by 
first intention using 0.5 Nylon (Ethicon, Johnson, USA) 
suture. Medications were prescribed, including:  0.12% 
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chlorhexidine gel twice daily for 15 days in the operated 
area, 500mg of Amoxicillin every 8 hours for 10 days, 
Paracetamol 750mg every 6 hours for three days and 
Benzalkonium Chloride (0.1mg + 9.0 mg Sodium Chlo-
ride - Sorine®) nasal solution four drops in each nostril 
six times per day for 10 days. The sutures were removed 
10 days after the surgery and the patients were monito-
red throughout the entire period.
The biomaterials used to graft the 74 sinuses analyzed 
were: Bio-Oss® Small=18, Bio-Oss® Large=10, Os-
teogen®=08, Bone Ceramic® + Emdogain®=10, Cera-
sorb®=11, Endobon®=17.
-CBCT evaluation
During the study period, at V1 (7 days) and V2 (180 
days), a total of 148 CBCT images, were obtained. The 
tomography images were analyzed by a single, expert, 
trained and blinded operator using Osirix® MD Ima-
ging 6.5 software (Pixmeo, Geneva, Switzerland), with 
a Kappa concordance index of 0.79. The variables maxi-
llary sinus size (total volume), with the mesiodistal, buc-
cal-palatal distances and height, were measured, and co-
rrelated with the volumetric changes of the grafts during 
the two healing periods. The images were delimited ma-
nually by the evaluator, and the program semi-automa-
tically defined all sagittal, axial and coronal reconstruc-
tions of the images as described for Favato (13), (Fig. 1). 
-Statistical analysis
The Kolmogorov-Smirnov test was used to determine 
the normal distribution of the data. The Kruskal-Wallis 
test was used at V1 and V2 to analyze the graft volume 
maintenance and the influence of the amount of bioma-
terials used.
Results
The final sample consisted of 148 computed tomography 
(CBCT) images of 74 grafts from 68 posterior maxillary 
edentulous patients, 23 males and 45 females, mean age 
of 56 years, referred for sinus lift. 
The amounts of biomaterials used were categorized in 
the following intervals, show in Table 1. The variable 
evaluated was the influence of the amount (weight in 
grams) of different biomaterials used in sinus lift, by 
measuring the volumetric changes of the grafts at 7 days 
and at 180 days.
The mean amounts of biomaterials used were: 1.58g of 
Bio-Oss® Small, 1.35g of Bio-Oss® Large, 0.72g of En-
Fig. 1: A total sinus volume was calculated after a manually delimited of area in several axial cuts A, and sagittal linear measure-
ment sinus height and width B. A total sinus volume of the graft was calculated after a manually delimited of area in several axial 
C and sagittal cuts D. The program calculated automatically the volume E.
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Bio-Oss® Small Group 1 (G₁) ≥ 1g ≤ 1.5g
Bio-Oss® Small Group 2 (G₂) ≥ 2g ≤ 2.5g;
Bio-Oss® Large Group 3 (G3) ≥ 0.50g ≤ 1.0g
Bio-Oss® Large Group 4 (G4) ≥ 1.5g ≤2.0g;
Endobon® Group 5 (G5)   ≥ 0.49 ≤ 0.73g
Endobon® Group 6 (G6) = 0.96g;
BoneCeramic® + Emdogaim® Group 7 (G7) ≥ 0.51 ≤ 1.01g;
Cerasorb® Group 8 (G8) ≥ 0.89 ≤ 1.77g
Osteogen® Group 9 (G9) ≥ 1.8g ≤ 2.5g;
Osteogen® Group 10 (G10) ≥ 3g ≤ 4.0g.
Table 1: Amounts of biomaterials used categorized in the following intervals.
dobon®, 0.96g of BoneCeramic® + Emdogaim®, 1.13g 
of Cerasorb® and 2.70g of Osteogen®. The means, me-
dians and standard deviations of the graft volumes obtai-
ned by all biomaterials in the two periods are described 
in Table 2. The influence of the categorized biomate-
rial groups according to amounts (weight-grams) used, 
in the initial and final volumes is described in Table 3. 
Multiple comparisons among these biomaterial groups 
were conducted using these data. Concerning the graft 
volume obtained at V1, no statistical differences were 
found p=0.415.
The purpose of regression analysis is determining the 
dependence of a variable on the independent or predic-
tive variable, assuming a linear model. In this way, the 
degree of linear relationship between the variables is 
strong or weak, depends on how the group of the points 
are located around an imaginary line that passes through 
the set of points.
Figure 2 presents the results of the grafts contractions 
according to mean amounts (gram weight) of bioma-
terials used at V1 are shown. It shows that increasing 
the mean amounts of biomaterials did not increase the 
Bio Oss® Small 2.03 1.30 1.79
Bio Oss® Large 1.82 0.70 1.81
V₁ Endobon® 1.59 0.44 1.53
Bone-Ceramic+Endogain ® 1.73 0.56 1.8
Cerasorb® 1.70 0.40 1.66
Osteogen®. 2.20 0.87 2.20
Bio Oss® Small 1.76 1.23 1.21
Bio Oss® Large 1.59 0.58 1.57
V₂ Endobon® 1.46 0.35 1.4
Bone-Ceramic+Endogain® 1.34 0.45 1.32
Cerasorb® 0.99 0.43 0.89
Osteogen®. 1.79 0.84 1.57
Table 2: Descriptions of volumes at V1 and V2 in cm3.
grafts volumes at V1. This correlation is weak in the 
mean amounts of biomaterials with the volumes of the 
grafts in V1. The biomaterial Osteogen® shows a larger 
amount in grams used but, did not influence the graft 
obtained at V1 when compared with the other grafts ob-
tained using other biomaterials. 
Figure 3 shows the linear regression analyses between 
the mean amounts of biomaterials used and the final 
mean graft contractions observed at V2. The group of 
points is distant from the regression line, so in this case it 
is not formed because the point group is dispersed what 
represent a weak correlation. The regression analyses 
at V2 showed that the correlation is very low (close to 
zero) among the analysed variables, and also show that 
if the amount of the biomaterials increases the final vo-
lume will not increase.
Comparisons of the initial volume (V1) and final volume 
(V2) according to the biomaterials groups were conducted.
Concerning the final volume obtained at V2 statistically 
significant differences (p=0.00003) can be found only in 
comparisons of four groups: Cerasorb® G8 x Bio-Oss® 
Small G2, Cerasorb® G8 x Endobon® G5, Cerasorb® G8 
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Amount in grams by biomaterials per group
Biomaterials Group Sinus Mean Median SD Mean Median SD IGC MGGC
BioOss Small® G1 9 1.674 1.290 +/-0.994 0.341 0.310 0.277 22.28% 14.98%
G2 9 2.398 2.330 +/-1.530 0.201 0.120 0.204 7.68%
BioOss Large® G3 6 1.527 1.740 +/-0.368 0.203 0.130 0.156 12.95% 11.93%
G4 4 2.507 2.160 +/-0.901 0.283 0.11 0.309 9.56%
Endobon® G5 12 1.550 1.500 +/-0.489 0.150 0.105 0.153 8.79% 8.04%
G6 5 1.718 1.850 +/-0.318 0.110 0.100 0.060 6.26%
BoneCeramic
+EMD®
G7 10 1.735 1.800 +/-0.567 0.391 0.385 0.236 21.83% 21.83%
Cerasorb® G8 11 1.705 1.660 +/-0.408 0.715 0.690 0.260 43.36% 43.36%
Osteogen® G9 4 2.077 2.200 +/-1.096 0.330 0.285 0.160 17.83% 20.43%




Table 3: The influence of the categorized biomaterial groups according to amounts (weight-grams) used, in the initial and final volumes. (IGC 
– Individual group contraction, MGGC – Mean of Graft/Groups Contraction).
Fig. 2: The volume graft obtained at V1 according to the mean amount of the biomaterial (in grams) used.
x Endobon® G6 and Cerasorb® G8 x Bio-Oss® Large 
G3 (Table 4).
Concerning the distribution of the means obtained at V1 
and V2, homogeneous distributions can be found with 
strong linear correlations for all biomaterials evaluated. 
A high value for R² (0.887) was found, showing a strong 
correlation between the variables V1 versus V2. Thus, 
all biomaterials showed significant contraction between 
V1 and V2.
Discussion
The present retrospective cross-sectional cohort ob-
servational study has established a correlation of the 
amount in weight of the xenogeneic hydroxyapatite 
and alloplastic hydroxyapatite biomaterials with the 
initial and final volumes of the grafts obtained using 
these biomaterials in sinus lift. It has also determi-
ned the final volume changes of grafts obtained, using 
CBCT images. The relationships and variables asses-
J Clin Exp Dent. 2020;12(9):e830-7.                                                                                                                                          Graft volumetric maintenance of biomaterials for maxillary sinus lift
e835
Material Volume at V1 Contraction Difference
Cerasorb® G8 x Bio-Oss® Small G2 1.70cm³ x 2.25cm
3 -0.71cm³/-0.18cm³ 25.35%
Cerasorb® G8 x Endobon® G5 1.70cm³ x 1.55cm
3 -0.71cm³/-0.15cm³ 21.13%
Cerasorb® G8 x Endobon® G6 1.70cm³ x 1.46cm
3 -0.71cm³/-0.24cm³ 33.80%
Cerasorb® G8 x Bio-Oss® Large G3 1.70cm³ x 1.53cm
3 -0.71cm³/-0.20cm³ 28.17%
(p<0.001) Volume V1 (15 days after the 
surgery)
Table 4: Multiple comparison among groups (Cerasorb® G1 ≥0.89g ≤1.77g, Bio-Oss® small G2 ≥2g ≤ 2.5g, Endobon® G1 ≥0.49g ≤ 
0.73g, Endobon® G2 = 0.96g, Bio-Oss® large G1 ≥0.50g ≤1.0g) with statistically significant differences concerning the final volume 
obtained at V2. (Contractions V1 – V2).
Fig. 3: Mean graft volumes at V2 according to the mean amounts of biomaterials in grams used.
sed in the present study have still not been identified 
in the literature.
Among the variables that may influence volumetric 
changes, it is important to highlight that factors such as 
the remaining alveolar bone or even total size/volume 
of the maxillary sinus may also influence the graft volu-
me maintenance. Volume graft reduction should be ex-
pected for the use of any biomaterial, particularly at the 
early stage of graft maturation (21). However, according 
to Favato et al. (13), when evaluating the variable maxi-
llary sinus size/volume with different biomaterials for 
grafting the maxillary sinus elevation, only determined 
that the type of biomaterial used in the graft acts as a 
volumetric alteration factor. 
The mean amounts in grams of biomaterials: Bio-Oss® 
Small (1.58g), Bio-Oss® Large (1.35g), Endobon® 
(0.72g), BoneCeramic® + Emdogaim® (0.96), Cera-
sorb® (1.13g) and Osteogen® (2.70g) did not present 
statistically significant differences. These biomaterials 
mean amounts were used to establish the correlation be-
tween initial and final graft volumes obtained.  Therefo-
re, the influence of this variable could be evaluated, and 
this proposition has not been reported in the literature. 
The results of the present study concerning xenogeneic 
hydroxyapatites Bio-Oss® Small, Bio-Oss® Large and 
Endobon® have demonstrated that the mean volumes 
obtained were 2.036cm³, 1.821cm³, 1.599cm3 respec-
tively at V1. For alloplastic hydroxyapatites Bone-Ce-
ramic®, Cerasorb® and Osteogen® were 1.735cm3, 
1.75cm3 and 2.204cm3, respectively at V1. The analysis 
of the correlation of this period shows that if the amount 
of the biomaterials is increased, the initial volume will 
not increase. It is suggested that these variations are 
associated with the structural features particle size and 
volume weight ratio, from each evaluated biomaterial. 
Although the limitations of there are no data in the litera-
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ture to establish a discussion of this variable and just on 
period of six months in the present study, is important to 
stresses that the long-term stability of the three-dimen-
sional bone increase is a determining factor for dental 
implant and aesthetic success according to Shanbhag et 
al. (25).
Thus, regardless of the type of graft biomaterial used, it 
is clear that it undergoes dimensional changes that may 
influence the final graft volume over time. In the present 
study, a final mean contraction of 18.71%, for all bio-
materials, was found at the end of the 180-day period. A 
mean volume reduction of 45% over six months to two 
years for autogenous bone. Bone substitute biomaterials 
or mixed grafts may offer greater volumetric stability 
than autogenous bone alone. Bone substitutes such as 
demineralized bovine bone or biphasic calcium phos-
phate, when used alone or in combination with other 
biomaterials (for example, autogenous bone), present an 
average 18% to 23% volumetric reduction. Consistent 
with the literature, (2,6,11,25). this behavior suggests 
the possible compromise of the stability of the implants 
installed in these grafts.
Individually analyzed, the mean contractions found for 
the grafts/biomaterials were: Bio-Oss® Small= 14.98%, 
Bio-Oss Large= 11.93%, Endobon®= 8.04%, Bone-Ce-
ramic®= 21.83%, Cerasorb®= 43.36% and Osteo-
gen®= 20.43%. A high-volume reduction was observed 
for Cerasorb® graft, similar to the autogenous graft con-
traction of up to 40% reduction of the final graft volume. 
This graft behavior data is consistent with that reported 
by Browaeys et al. (2).
To determine the influence of the amount of biomaterial 
on the volumetric changes of the grafts, the present study 
categorized groups by gram intervals and established 
multiple comparisons. It was found, at final volume V2, 
that all Cerasorb® groups presented a significant diffe-
rence in the contractions. These data are very important 
for the biomaterial choice in sinus lift graft planning.
Concerning the amounts of biomaterials used and the 
final contractions found with xenogeneic hydroxyapati-
tes in maxillary sinus lift, the similarity of the results to 
Chackartchi et al. (4), Cosso et al. (11), Testori et al. (15) 
can be inferred with the data of the present study. In this 
context, it is difficult to have a more thorough discussion 
with more specific studies because the scientific infor-
mation available concerning the influence of the amount 
of biomaterial used on initial and final graft volumes 
during maxillary sinus lift has still not been identified 
in the literature. In contrast to the findings in the litera-
ture, which present Cerasorb® (pure β-TCP phase) as a 
bone substitute comparable to other biomaterials used 
in maxillary sinus lift (26) the present study shows that 
Cerasorb® has a higher resorption rate. Analyzing the 
composition of this biomaterial, it was found to be fu-
lly absorbable with no residues of the graft biomaterial. 
Apparently, the greater amount of the biomaterial was 
resorbed and replaced by bone, which presented a faster 
resorption rate than the Bio-Oss® type materials (26). 
Endobon®, a non-absorbable porous bovine hydroxya-
patite with porosity between 45% and 80% (11,28) was 
the biomaterial that presented less resorption when com-
pared with all the evaluated biomaterials in the present 
study.
As reported in the literature (3,10,25-30) there is still a 
deficiency to determine the best osseointegration predic-
tability for installed implants, as well as for aesthetics, 
concerning the volumetric stability of grafts obtained 
with different biomaterials after maxillary sinus lift. 
Further controlled and longitudinal investigations are 
needed to verify the impact of the biomaterial amount 
on the graft volumetric changes using different biomate-
rials over longer control periods. In this context, studies 
like the present one take on increasing importance with 
regard the predictability of osseointegrated implants ins-
talled in grafted sinus lift areas.
Conclusions
Tricalcium phosphate Cerasorb® presented statistically 
significant contraction were compared to the other bio-
material groups.
The amount of biomaterial used could influence the final 
graft volume depending on the biomaterial characteristics.
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